✦ LIBER ✦

Animal models of Parkinson’s disease and L-dopa induced dyskinesia: How close are we to the clinic?

✍ Scribed by Emma Lane; Stephen Dunnett

Publisher: Springer
Year: 2007
Tongue: English
Weight: 205 KB
Volume: 199
Category: Article
ISSN: 0033-3158
DOI: 10.1007/s00213-007-0931-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison between the decrease of dopam

Comparison between the decrease of dopamine transporter and that of L-DOPA uptake for detection of early to advanced stage of Parkinson's disease in animal models

✍ Yasushi Ito; Masahiro Fujita; Shoichi Shimada; Yoshiyuki Watanabe; Tomoya Okada; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

Early diagnosis of Parkinson's disease (PD) is important for the potential application of neuroprotective therapies. The purpose of this study was to assess the detection of the early changes of PD by either imaging the dopamine transporter (DAT) or uptake of L-3,4-dihydroxyphenylalanine (L-DOPA). A

The α2-adrenergic receptor antagonist id

The α2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease

✍ Brian Henry; Susan H. Fox; David Peggs; Alan R. Crossman; Jonathan M. Brotchie 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

The role of anxiety in the development o

The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson’s disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram

✍ Wei-Li Kuan; Jing-Wei Zhao; Roger A. Barker 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 491 KB